Cargando…
P969: COMPARISON OF VENOUS THROMBOEMBOLISM INCIDENCE IN MULTIPLE MYELOMA PATIENTS RECEIVING LENALIDOMIDE-BASED REGIMENS WITH RIVAROXABAN OR ASPIRIN THROMBOPROPHYLAXIS
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429082/ http://dx.doi.org/10.1097/01.HS9.0000846744.38970.75 |
| _version_ | 1784779323083849728 |
|---|---|
| author | Wang, Y. Tang, X. Zheng, W. Wang, Z. Xu, J. Tan, X. Tian, Y. Xu, R. Cui, S. |
| author_facet | Wang, Y. Tang, X. Zheng, W. Wang, Z. Xu, J. Tan, X. Tian, Y. Xu, R. Cui, S. |
| author_sort | Wang, Y. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9429082 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94290822022-08-31 P969: COMPARISON OF VENOUS THROMBOEMBOLISM INCIDENCE IN MULTIPLE MYELOMA PATIENTS RECEIVING LENALIDOMIDE-BASED REGIMENS WITH RIVAROXABAN OR ASPIRIN THROMBOPROPHYLAXIS Wang, Y. Tang, X. Zheng, W. Wang, Z. Xu, J. Tan, X. Tian, Y. Xu, R. Cui, S. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429082/ http://dx.doi.org/10.1097/01.HS9.0000846744.38970.75 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Wang, Y. Tang, X. Zheng, W. Wang, Z. Xu, J. Tan, X. Tian, Y. Xu, R. Cui, S. P969: COMPARISON OF VENOUS THROMBOEMBOLISM INCIDENCE IN MULTIPLE MYELOMA PATIENTS RECEIVING LENALIDOMIDE-BASED REGIMENS WITH RIVAROXABAN OR ASPIRIN THROMBOPROPHYLAXIS |
| title | P969: COMPARISON OF VENOUS THROMBOEMBOLISM INCIDENCE IN MULTIPLE MYELOMA PATIENTS RECEIVING LENALIDOMIDE-BASED REGIMENS WITH RIVAROXABAN OR ASPIRIN THROMBOPROPHYLAXIS |
| title_full | P969: COMPARISON OF VENOUS THROMBOEMBOLISM INCIDENCE IN MULTIPLE MYELOMA PATIENTS RECEIVING LENALIDOMIDE-BASED REGIMENS WITH RIVAROXABAN OR ASPIRIN THROMBOPROPHYLAXIS |
| title_fullStr | P969: COMPARISON OF VENOUS THROMBOEMBOLISM INCIDENCE IN MULTIPLE MYELOMA PATIENTS RECEIVING LENALIDOMIDE-BASED REGIMENS WITH RIVAROXABAN OR ASPIRIN THROMBOPROPHYLAXIS |
| title_full_unstemmed | P969: COMPARISON OF VENOUS THROMBOEMBOLISM INCIDENCE IN MULTIPLE MYELOMA PATIENTS RECEIVING LENALIDOMIDE-BASED REGIMENS WITH RIVAROXABAN OR ASPIRIN THROMBOPROPHYLAXIS |
| title_short | P969: COMPARISON OF VENOUS THROMBOEMBOLISM INCIDENCE IN MULTIPLE MYELOMA PATIENTS RECEIVING LENALIDOMIDE-BASED REGIMENS WITH RIVAROXABAN OR ASPIRIN THROMBOPROPHYLAXIS |
| title_sort | p969: comparison of venous thromboembolism incidence in multiple myeloma patients receiving lenalidomide-based regimens with rivaroxaban or aspirin thromboprophylaxis |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429082/ http://dx.doi.org/10.1097/01.HS9.0000846744.38970.75 |
| work_keys_str_mv | AT wangy p969comparisonofvenousthromboembolismincidenceinmultiplemyelomapatientsreceivinglenalidomidebasedregimenswithrivaroxabanoraspirinthromboprophylaxis AT tangx p969comparisonofvenousthromboembolismincidenceinmultiplemyelomapatientsreceivinglenalidomidebasedregimenswithrivaroxabanoraspirinthromboprophylaxis AT zhengw p969comparisonofvenousthromboembolismincidenceinmultiplemyelomapatientsreceivinglenalidomidebasedregimenswithrivaroxabanoraspirinthromboprophylaxis AT wangz p969comparisonofvenousthromboembolismincidenceinmultiplemyelomapatientsreceivinglenalidomidebasedregimenswithrivaroxabanoraspirinthromboprophylaxis AT xuj p969comparisonofvenousthromboembolismincidenceinmultiplemyelomapatientsreceivinglenalidomidebasedregimenswithrivaroxabanoraspirinthromboprophylaxis AT tanx p969comparisonofvenousthromboembolismincidenceinmultiplemyelomapatientsreceivinglenalidomidebasedregimenswithrivaroxabanoraspirinthromboprophylaxis AT tiany p969comparisonofvenousthromboembolismincidenceinmultiplemyelomapatientsreceivinglenalidomidebasedregimenswithrivaroxabanoraspirinthromboprophylaxis AT xur p969comparisonofvenousthromboembolismincidenceinmultiplemyelomapatientsreceivinglenalidomidebasedregimenswithrivaroxabanoraspirinthromboprophylaxis AT cuis p969comparisonofvenousthromboembolismincidenceinmultiplemyelomapatientsreceivinglenalidomidebasedregimenswithrivaroxabanoraspirinthromboprophylaxis |